Find real-time KALA - Kala Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business.

2020-06-06

Company Name: Kala Pharmaceuticals, Stock Symbol: KALA, Industry: Biotechs, Total Posts: 61, Last Post: 4/5/2021 4:56:15 PM Get Kala Pharmaceuticals Inc (KALA:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary nanoparticle-based Mucus Penetrating Particles (MPP) technology for the treatment of eye diseases. Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that Cigna has added EYSUVIS (loteprednol etabonate ophthalmic suspension) 0.25% as a preferred brand on its commercial formulary, effective May 15, 2021. On average, Wall Street analysts predict that .

Kala pharmaceuticals stock

Today Kala Pharmaceuticals currently has 1 hold rating and 6 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe KALA will outperform the market and that investors should add to their positions of Kala Pharmaceuticals. View the latest ratings for KALA. 2021-03-29 Get Kala Pharmaceuticals Inc (KALA:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

2021-04-12 · Get the latest Kala Pharmaceuticals (KALA) stock price quote with real-time news, financials, charts and other important investing information.

View Kala Pharmaceuticals, Inc. KALA investment & stock information. Get the latest Kala Pharmaceuticals, Inc. KALA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Detta innehåll är endast för prenumeranter. Registrera dig för en kostnadsfri provperiod. Registrering förbinder dig inte till att köpa Zenostock. Registrera

Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary nanoparticle-based Mucus Penetrating Particles (MPP) technology for the treatment of eye diseases. 2020-12-25 Kala Pharmaceuticals stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Kala Pharmaceuticals daily returns and investor perception about the current pice of Kala Pharmaceuticals as well as its diversification or hedging effects on your existing portfolios.

+1-857-277-4842. loraine.spreen@kalarx.com. Stock Quote & Chart. Stock Quote & Chart. Historical Price Lookup. Investment Calculator. I dag · Kala Pharmaceuticals, Inc. (NASDAQ:KALA)’s Major holders.
Spaniens ekonomiska kris

The grants were approved by the Compensation Committee and were made as an inducement material to each employee entering into employment with Kala Pharmaceuticals in accordance with … Find the latest Kala Pharmaceuticals, Inc. (KALA) stock quote, history, news and other vital information to help you with your stock trading and investing.

Find real-time KALA - Kala Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. View Kala Pharmaceuticals, Inc. KALA investment & stock information.
Hela malmö nydala

View Kala Pharmaceuticals, Inc. KALA investment & stock information. Get the latest Kala Pharmaceuticals, Inc. KALA detailed stock quotes, stock data,

2021-01-20 · Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards o 2020-12-25 · Jefferies have made an estimate for Kala Pharmaceuticals Inc. shares, keeping their opinion on the stock as Hold, with their previous recommendation back on September 14, 2020. The new note on the price target was released on July 23, 2020, representing the official price target for Kala Pharmaceuticals Inc. stock. Find real-time KALA - Kala Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. Kala Pharmaceuticals, Inc. (“Kala”) (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, announced today that it has commenced an underwritten public offering of $100.0 million of its common stock. 2021-03-25 · Kala Pharmaceuticals Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $9.97 on 02/08/21, with the lowest value was $6.39 for the same time period, recorded on 03/05/21. The Investor Relations website contains information about Kala Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.